SCHEMBL1950778

SCHEMBL1950778

CCCC(NC(=O)C1CC1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.48
LMNA P02545 2/20 0.48
TP53 P04637 1/20 0.46
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
FPR2 P25090 1/20 0.42
NOD1 Q9Y239 1/20 0.39
CHRM1 P11229 1/20 0.39
AKR1A1 P14550 1/20 0.39
CHRM3 P20309 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
ADRA1A P35348 1/20 0.39
HRH1 P35367 1/20 0.39
DRD3 P35462 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
MME P08473 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1950775 1.00 TDP1 (0.48) TDP1LMNATP53KMT2AMEN1
SCHEMBL10669991 0.93 LMNA (0.43) TDP1LMNATP53KMT2AMEN1
SCHEMBL10669986 0.93 LMNA (0.43) TDP1LMNATP53KMT2AMEN1
SCHEMBL23441778 0.93 RECQL (0.44) TDP1LMNATP53KMT2AMEN1
SCHEMBL9829322 0.91 NAAA (0.45) TDP1LMNAKMT2AMEN1
SCHEMBL9829324 0.91 NAAA (0.45) TDP1LMNAKMT2AMEN1
SCHEMBL1951843 0.89 TP53 (0.50) TDP1LMNATP53KMT2AMEN1
SCHEMBL1951845 0.89 TP53 (0.50) TDP1LMNATP53KMT2AMEN1
SCHEMBL25046028 0.89 TP53 (0.50) TDP1LMNATP53KMT2AMEN1
SCHEMBL12630399 0.85 TP53 (0.39) TDP1LMNATP53KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2507232-B1 PROLINE DERIVATIVES NATIONAL HEALTH RES INST (TW) 2019-03-20 EP disclosed
CN-102482269-B Proline derivatives NATIONAL HEALTH RESEARCH INSTITUTES (CN) 2015-07-29 CN disclosed
US-8415482-B2 Proline derivatives NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2013-04-09 US disclosed
CN-102482269-A Proline derivatives NAT HEALTH RESEARCH INSTITUTES 2012-05-30 CN disclosed
US-20110136799-A1 PROLINE DERIVATIVES NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2011-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110136799-A1 PROLINE DERIVATIVES PNISR, ARGLU1, PRR12 TDP1 2741/4885LMNA 2863/4885TP53 1280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.